Main Article Content


The currently available locally acting formulations to treat recurrent aphthous stomatitis (RAS) are either less efficacious or they are not comfortable for the use in the patients. Lozenges are one of the locally acting palatable oral formulations that may be used for the treatment of RAS. The aim of the present research work was to formulate locally acting efficacious herbal lozenges for the treatment of RAS which can provide a good patient compliance. As the part of preformulation study, estimation of secondary plant metabolites (Total phenolics and flavanoids) and compatibility study was carried out to formulate lozenges by moulding method. Trial batches were prepared for the optimization of bases (Isomalt, Liquid glucose and Honey) to formulate lozenges. The evaluation tests i.e. moulding time, hardness, friability, weight variation, in vitro drug release were carried out for the optimization of the batch. Evaluation of batches LC-LOZ 1 to LC-LOZ 9 was carried out. The diameter, thickness and hardness of lozenges were found to be 14.87±0.077mm, 7.15±0.005mm and147±0.16 N respectively. The weight uniformity was found to be 1.1±0.11 gm. The friability of lozenges was found to be less than 1% .The weight variation of all the formulations was found to be close to 1 gm which complied with the official standards. In clinical study the patients were divided into two groups and the number and size of ulcers were measured at baseline. After the treatment, follow up was taken after 24 hours, 48 hours and 72 hours. LC-LOZ was found to be more effective than Alarsin, a routinely used marketed formulation.


RAS (Recurrent Aphthous Stomatitis) Phenolics Flavanoids

Article Details

How to Cite
Kesha Desai, Mitesh Kataria, Dr. Ankur Talavia, & Dr. Ramesh K. Goyal. (2021). Formulation development and evaluation of herbal lozenges for the treatment of recurrent aphthous stomatitis. International Journal of Research in Pharmacology & Pharmacotherapeutics, 5(4), 318-325. Retrieved from


  1. [1]. Zain R “Classification, epidemiology and aetiology of oral recurrent aphthous ulceration stomatitis”. Annal Dent Univ Malaya 6, 1999, 34 - 37.
  2. [2]. Jurge S, Kuffer R. “Recurrent aphthous stomatitis”, Mucosal disease series 12, 1, 1–21
  3. [3]. 3 Crispian S, Meir G “The diagnosis and management of recurrent of aphthous stomatitis” American Dental Association, 134, 2003, 200-7.
  4. [4]. Ahmed M. Al-Abbasi (2010)attempted to evaluate the therapeutic effect of local application of Trichloroacetic Acid (TCA), hydrogen peroxide (H2O2) and normal saline for aphthous ulcers minor (AUM) and he found that TCA was more effective than H202.
  5. [5]. UNESCO: Culture and Health, Orientation-Texts World Decade for Culture Development 1988-1997. Document CLT/DEC/PRO. Paris, France; 1996.
  6. [6]. C. Scully and D. H. Felix “Oral medicine — Update for the dental practitioner Aphthous and other common ulcers” B. Dent. J. 199 No. 5 ,2005 , 259-264
  7. [7]. Tewari. S& Trembalowiz.F “Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect” by medicinal journal of Gut, 1968, 48-51.
  8. [8]. Pundir S.” Formulation Development and Evaluation of Antiemetic Lozenges of Ondansetron Hydrochloride”,int j of pharmaceutical research and bio-science, 3(3), 2014, 365-372
  9. [9]. Baharam T., Gressier B., Trotin F., Brunet C., Dine T., Pinkash M. Drug Research, 46, 1996, 1986-1989.
  10. [10]. Anonymous: WHO Guidelines, 1st ed. Delhi, A.I.T.B.S. Publishers and distributors, 2002, 45-46.
  11. [11]. Singleton VL, Rossi JA: Colorimetry of total phenolics with phosphomolybdic phosphotungustic acid reagent. American J Enology Viticulture, 16, 1965, 144 -158.
  12. [12]. Benbassad N. et al,”Development and evaluation of novel lozenges containing marshmallow root extract”,Pak. Jornal of Pharma Science., 26(6), 2013, 1103-1107.
  13. [13]. Pundir S.” Formulation Development and Evaluation of Antiemetic Lozenges of Ondansetron Hydrochloride”,int j of pharmaceutical research and bio-science 3(3), 2014, 365-372
  14. [14]. Katti G.” Amlexanox in the treatment of recurrent minor aphthous ulcers”,Intenational Journal of Dental Clinics, 3(3), 2011, 23-26.
  15. [15]. Vicente M, Soria A, Mosquera A, Pérez J, Lamas A, Castellano T, et al. Immunoglobulin G subclass measurements in recurrent aphthous stomatitis. Journal of Oral Pathology & Medicine. 25(10), 1996, 538-40.
  16. [16]. Savage N, Mahanonda R, Seymour G, Bryson G, Collins R. The proportion of suppressor inducer T lymphocytes is reduced in recurrent aphthous stomatitis. Journal of Oral Pathology & Medicine. 17(6), 1988, 293-297.
  17. [17]. Richards RM and Xinq DK “In vitro evaluation of the antimicrobial activities of selected lozenges. Journal of Pharma Science, 82(2), 1993, 1218-1220.
  18. [18]. Panduranga M et al, “A Clinical Study on Recurrent Aphthous Stomatitis: An Assessment of Multiple Etological Factors”. Journal of Evolution of Medical and Dental Sciences 3(64), 2014, 13963-13970.
  19. [19]. Karuna S et al, “Antioxidant potential of young pods of Acacia catechu wild collected from Jabalpur region”. Journal of Pharmacognosy and Phytochemistry 2(6), 2014, 68-73.
  20. [20]. Karami, Z, Mirzaei, H “Effect of harvest time on antioxidant activity of Glycyrrhiza glabra root extract and evaluation of its antibacterial activity”, International Food Research Journal 20(5), 2013, 2951-2957.
  21. [21]. Arabshahi-Delouee, S. and Urooj, A. Antioxidant properties of various solvent extracts of mulberry (Morusindica L.) leaves. Food Chemistry 102, 2007, 1233– 1240.